ITIF Search

Kelli Zhao


Policy Analyst, Economics of Biopharmaceutical Innovation

Email: [email protected]

Zhao is a policy analyst focusing on the economics of biopharmaceutical innovation. She holds a M.Sc. in international health policy (health economics) from the London School of Economics and Political Sciences and a B.A. in economics from the University of Sydney. Previously she worked as a research assistant at The George Institute for Global Health in Australia.

Recent Publications

March 20, 2023

The Economics of Biopharmaceutical Innovation: Symposium Report

Investments in biopharmaceutical innovation and expenditures on medicines themselves both produce tremendous societal returns. Maintaining the robust innovation ecosystem necessary to capitalize on these benefits requires the right mix of “push” and “pull” incentives.

More publications by Kelli Zhao

Back to Top